J&J, other drugmakers to face trial in California over claims they fueled opioid epidemic

Four drugmakers are set to face trial on Monday in a lawsuit by several large counties in California that are seeking more than $50 billion over claims the companies helped fuel an opioid epidemic by deceptively marketing addictive painkillers. The case against Johnson & Johnson, Teva Pharmaceutical Industries Ltd, Endo International PLC, and AbbVie's Allergan unit is one of the thousands of lawsuits by states and local governments seeking to hold pharmaceutical companies responsible for the drug crisis.

Reuters | Washington DC | Updated: 19-04-2021 15:45 IST | Created: 19-04-2021 15:33 IST
J&J, other drugmakers to face trial in California over claims they fueled opioid epidemic
Representative image Image Credit: Twitter(@SAgovnews)

Four drugmakers are set to face trial on Monday in a lawsuit by several large counties in California that are seeking more than $50 billion over claims the companies helped fuel an opioid epidemic by deceptively marketing addictive painkillers.

The case against Johnson & Johnson, Teva Pharmaceutical Industries Ltd, Endo International PLC, and AbbVie's Allergan unit is one of the thousands of lawsuits by states and local governments seeking to hold pharmaceutical companies responsible for the drug crisis. Opioids have resulted in the overdose deaths of nearly 500,000 people from 1999 to 2019 in the United States, according to U.S. Centers for Disease Control and Prevention.

The populous Santa Clara, Los Angeles, and Orange Counties, and the city of Oakland accuse the companies of deceptively marketing painkillers in ways that downplayed their addictive risks. The drugmakers argue they acted appropriately and that they did not cause the epidemic. If Orange County Superior Court Judge Peter Wilson finds the companies liable following a non-jury trial, the counties say the companies should have to pay $50 billion to cover the costs of abating the public nuisance they created plus penalties.

More than 3,400 similar lawsuits are pending nationally over the opioid epidemic. The only other case to go to trial in the opioid litigation resulted in the state of Oklahoma in 2019 winning a $465 million judgment against J&J, which is appealing. Other cases are slated to go to trial in the coming months, creating new pressure for the companies to reach settlements.

The nation's three largest drug distributors - McKesson Corp, AmerisourceBergen Corp, and Cardinal Health Inc - and J&J have proposed paying a combined $26 billion to resolve the cases against them. The proposed deal has not been finalized.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Blockchain in Healthcare: Opportunities and challenges

The use of blockchain in healthcare is a relatively new innovation with many of its uses still being explored and related technologies being developed, improved, and scaled. ...

Debate surrounding vaccine passports and development misses bigger picture

... ...

Blockchain vs IOTA: Looking for a better alternative

... ...

For stability, Iraq needs to crack down on corruption

... ...

Videos

Latest News

Kabul school bombing condemned by senior UN officials

Most of the casualties are reported to be girls, who were leaving the building at the end of the school day. According to media reports, the city was full of shoppers, ahead of the Eid-al-Fitr celebrations.Henrietta Fore, the Executive Dire...

The United Nations remembers the dead of WWII

In total, about 40 million civilians, and some 20 million soldiers, almost half of them Russians, lost their lives in the war between 1939 and 1945. On 8 and 9 May, the UN invites its 193 member countries, non-governmental organizations, an...

Car bombing at Afghan school in Kabul kills 55, injures over 150

Explosions caused by a car bomb and mortars outside a school in the Afghan capital Kabul on Saturday killed at least 55 people and wounded over 150, mostly female students, officials said, in an attack, President Ashraf Ghani blamed on Tali...

Rajasthan govt will consider importing COVID-19 vaccines: Gehlot

Rajasthan Chief Minister Ashok Gehlot on Saturday said his government will consider importing COVID-19 vaccines to ensure that people in the state are inoculated against the viral disease at the earliest.Speaking at a high-level meeting hel...

Give Feedback